John E. Ultmann

3.8k total citations · 1 hit paper
99 papers, 2.9k citations indexed

About

John E. Ultmann is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John E. Ultmann has authored 99 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 29 papers in Genetics and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John E. Ultmann's work include Lymphoma Diagnosis and Treatment (38 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lung Cancer Treatments and Mutations (10 papers). John E. Ultmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (38 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lung Cancer Treatments and Mutations (10 papers). John E. Ultmann collaborates with scholars based in United States, United Kingdom and Canada. John E. Ultmann's co-authors include Edward L. Amorosi, Alfred Gellhorn, Harvey M. Golomb, Donald L. Sweet, Richard K. Desser, Jacob D. Bitran, Edgar M. Moran, Erich Hirschberg, M. J. Tannenbaum and Janet D. Rowley and has published in prestigious journals such as Science, JAMA and Journal of Clinical Oncology.

In The Last Decade

John E. Ultmann

94 papers receiving 2.5k citations

Hit Papers

THROMBOTIC THROMBOCYTOPENIC PURPURA 1966 2026 1986 2006 1966 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. THROMBOTIC THROMBOCYTOPENIC PURPURA
    1966 699 citations Edward L. Amorosi, John E. Ultmann Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Ultmann United States 28 1.0k 869 628 596 591 99 2.9k
William C. Moloney United States 36 1.2k 1.2× 530 0.6× 1.2k 1.8× 1.0k 1.7× 1.4k 2.4× 132 4.8k
Sanford Kempin United States 33 1.0k 1.0× 658 0.8× 1.2k 1.9× 1.1k 1.8× 1.6k 2.7× 69 3.9k
Isaac Ben‐Bassat Israel 34 674 0.7× 600 0.7× 816 1.3× 587 1.0× 1.3k 2.2× 140 3.2k
Jean‐Paul Fermand France 34 445 0.4× 792 0.9× 890 1.4× 1.4k 2.4× 1.8k 3.1× 105 4.4k
Dolors Tàssies Spain 30 346 0.3× 578 0.7× 284 0.5× 295 0.5× 842 1.4× 117 3.0k
C. P. Engelfriet Netherlands 37 345 0.3× 1.2k 1.3× 475 0.8× 229 0.4× 3.2k 5.4× 153 4.7k
Antonio Salar Spain 28 1.8k 1.7× 519 0.6× 819 1.3× 1.2k 2.0× 292 0.5× 153 3.0k
Gil Tchernia France 42 1.1k 1.1× 1.2k 1.4× 2.3k 3.7× 482 0.8× 2.1k 3.5× 198 6.7k
Hideto Kameda Japan 38 628 0.6× 1.2k 1.3× 631 1.0× 398 0.7× 1.2k 2.0× 196 4.3k
Byron M. Espina United States 29 959 0.9× 433 0.5× 330 0.5× 1.6k 2.8× 438 0.7× 73 3.5k

Countries citing papers authored by John E. Ultmann

Since Specialization
Citations

This map shows the geographic impact of John E. Ultmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Ultmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Ultmann more than expected).

Fields of papers citing papers by John E. Ultmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Ultmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Ultmann. The network helps show where John E. Ultmann may publish in the future.

Co-authorship network of co-authors of John E. Ultmann

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Ultmann. A scholar is included among the top collaborators of John E. Ultmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Ultmann. John E. Ultmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ultmann, John E., et al.. (1997). For Germany, better late than never in biotech race.. Annals of Oncology. 8(1+). 1–3. 9 indexed citations
2.
Boivin, J.‐F., George B. Hutchison, Ann G. Zauber, et al.. (1995). Incidence of Second Cancers in Patients Treated for Hodgkin's Disease. JNCI Journal of the National Cancer Institute. 87(10). 732–741. 148 indexed citations
3.
Olopade, Olufunmilayo I. & John E. Ultmann. (1991). Malignant effusions. CA A Cancer Journal for Clinicians. 41(3). 166–179. 17 indexed citations
4.
Samuels, Brian L. & John E. Ultmann. (1991). The fourth international conference on malignant lymphoma. Annals of Oncology. 2. 1–7. 15 indexed citations
5.
Larson, Richard A., et al.. (1990). Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.. PubMed. 4(2). 127–31. 2 indexed citations
6.
Samuels, Brian L. & John E. Ultmann. (1989). Lymphomas—Current Progress and Future Directions. Perspectives in biology and medicine. 32(4). 513–525.
7.
Hallahan, Dennis E., Everett E. Vokes, Jacob D. Bitran, et al.. (1989). The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. International Journal of Radiation Oncology*Biology*Physics. 17(4). 767–771. 19 indexed citations
8.
Williams, Stephanie, Richard L. Schilsky, John E. Ultmann, et al.. (1988). The Role of High-Dose Therapy and Autologous Bone Marrow Reinfusion in the Treatment of Malignant Lymphomas. Cancer Investigation. 6(4). 427–437. 3 indexed citations
9.
Carter, Stephen K. & John E. Ultmann. (1984). Peplomycin. Cancer Treatment Reviews. 11(4). 303–305. 5 indexed citations
10.
Kanofsky, Jeffrey R., et al.. (1981). Late relapses in hodgkin disease. American Journal of Hematology. 10(1). 31–36. 12 indexed citations
11.
Mintz, Uri, John B. Miller, Harvey M. Golomb, et al.. (1979). Pathologic stage I and II Hodgkin's disease, 1968-1975. Relapses and results of retreatment. Cancer. 44(1). 72–79. 14 indexed citations
12.
Moran, Edgar M. & John E. Ultmann. (1974). Clinical features and course of Hodgkin's disease. Clinics in Haematology. 3(1). 91–129. 7 indexed citations
13.
Desser, Richard K., Edgar M. Moran, & John E. Ultmann. (1973). Staging of Hodgkin’s Disease and Lymphoma: Diagnostic Procedures Including Staging Laparotomy and Splenectomy. Medical Clinics of North America. 57(2). 479–498. 30 indexed citations
14.
Ultmann, John E.. (1967). Fine-Needle Aspiration Biopsy.. Archives of Internal Medicine. 120(2). 254–254. 11 indexed citations
15.
Amorosi, Edward L. & John E. Ultmann. (1966). THROMBOTIC THROMBOCYTOPENIC PURPURA. Medicine. 45(2). 139–160. 699 indexed citations breakdown →
16.
Ultmann, John E.. (1965). The Physiology of Blood Platelets: Recent Biochemical, Morphologic and Clinical Research.. Archives of Internal Medicine. 116(6). 966–966. 6 indexed citations
17.
Ultmann, John E., Philip Feigelson, & Susanne Harris. (1962). The Effect of Specific Antibodies on Xanthine Oxidase from Various Sources. The Journal of Immunology. 88(1). 113–120. 11 indexed citations
18.
Gellhorn, Alfred, et al.. (1961). The Use of Atabrine (Quinacrine) in the Control of Recurrent Neoplastic Effusions. Diseases of the Chest. 39(2). 165–176. 45 indexed citations
19.
Koprowska, I, John E. Ultmann, & Ralph L. Engle. (1960). Cytology of Lymph Node Imprints. CA A Cancer Journal for Clinicians. 10(6). 200–207. 1 indexed citations
20.
Ultmann, John E., I Koprowska, & Ralph L. Engle. (1958). A cytological study of lymph node imprints. Cancer. 11(3). 507–524. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William C. Moloney Breakdown of academic impact, for papers by Sanford Kempin Breakdown of academic impact, for papers by Isaac Ben‐Bassat Breakdown of academic impact, for papers by Jean‐Paul Fermand Breakdown of academic impact, for papers by Dolors Tàssies Breakdown of academic impact, for papers by C. P. Engelfriet Breakdown of academic impact, for papers by Antonio Salar Breakdown of academic impact, for papers by Gil Tchernia Breakdown of academic impact, for papers by Hideto Kameda Breakdown of academic impact, for papers by Byron M. Espina
Rankless by CCL
2026